drugset / Trial / NCT04357795
Effect of Cequa™ in Subjects With Dry Eye Disease
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 4, multicenter, single arm, 12 week study in subjects with dry eye disease, which is inadequately controlled by cyclosporine 0.05% ophthalmic emulsion.
Timeline
- Start
- 2020-06-29
- Primary completion
- 2022-06-24
- Completion
- 2022-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.09 % | Other |